By Counterforce Health Team in Fintepla (fenfluramine) —

How Long Does It Take to Get Fintepla (Fenfluramine) Approved by Aetna (CVS Health) in New Jersey? Complete Timeline & Appeals Guide

Answer Box: Getting Fintepla Approved by Aetna (CVS Health) in New Jersey

Standard timeline: 15-30 days for prior authorization; 72 hours for urgent cases. Aetna requires documented failure of ≥2 preferred antiseizure medications, REMS enrollment (prescriber and patient), and baseline echocardiogram for Dravet syndrome or Lennox-Gastaut syndrome patients ≥2 years old. If denied, New Jersey's Independent Health Care Appeals Program (IHCAP) provides external review within 45 days. Start today: Call Aetna member services at 1-800-872-3862 to verify specialty pharmacy benefit and download the Specialty Medication Precertification Request form.

Table of Contents

  1. What Affects Fintepla Approval Timing
  2. Pre-Submission Preparation (0-2 Days)
  3. Submission to Initial Review (1-5 Days)
  4. Additional Information Requests (1-7 Days)
  5. Decision Window & Outcomes
  6. If Denied: New Jersey Appeals Process
  7. Renewal Cycles & Reauthorization
  8. Timeline Visual & Milestones
  9. Time-Saving Tips
  10. Common Denial Reasons & Fixes
  11. FAQ

What Affects Fintepla Approval Timing

Several factors determine how quickly Aetna (CVS Health) processes your Fintepla (fenfluramine) prior authorization in New Jersey:

Benefit Type: Fintepla is typically covered under Aetna's specialty pharmacy benefit, requiring coordination with CVS Specialty or designated network pharmacies.

Complexity of Criteria: Aetna's Fintepla clinical policy mandates multiple requirements: confirmed Dravet syndrome or LGS diagnosis, neurologist prescription, documented failure of preferred ASMs, and FDA REMS compliance with echocardiogram monitoring.

Documentation Completeness: Incomplete submissions trigger additional information requests, extending approval by 5-10 days. Missing REMS enrollment or echocardiogram reports are the most common delays.

Tip: Urgent requests (where delay could seriously jeopardize health) receive expedited 72-hour review when properly documented.

Pre-Submission Preparation (0-2 Days)

Verification Checklist

Before submitting your prior authorization, gather these essential items:

Insurance Information:

  • Aetna member ID and group number
  • Confirm specialty pharmacy benefit coverage by calling 1-800-872-3862
  • Verify if Fintepla requires step therapy or quantity limits

Clinical Documentation:

  • Confirmed diagnosis with ICD-10 codes (Dravet: G40.83; LGS: G40.81/G40.82)
  • Detailed seizure history and frequency logs
  • Documentation of ≥2 failed preferred antiseizure medications with specific doses, durations, and outcomes
  • Baseline echocardiogram report showing no valvular heart disease or pulmonary arterial hypertension

REMS Requirements:

  • Prescriber enrollment in Fintepla REMS program
  • Patient enrollment completion
  • Selection of REMS-certified specialty pharmacy

Key Forms & Contacts

Submission to Initial Review (1-5 Days)

Once Aetna receives your complete prior authorization, the initial review process begins:

Standard Processing: 15-30 days for complete submissions, consistent with New Jersey insurance regulations for specialty medications.

Expedited Processing: 72 hours for urgent cases where delay poses serious health risks (frequent uncontrolled seizures, status epilepticus history).

What Reviewers Check First:

  1. Plan coverage verification and formulary status
  2. Diagnosis confirmation and ICD-10 coding accuracy
  3. Prescriber credentials (neurologist or epileptologist requirement)
  4. REMS enrollment status for all parties
  5. Step therapy compliance (documented ASM failures)
  6. Baseline echocardiogram results and cardiac clearance
Note: Electronic submissions through Aetna's provider portal typically process faster than fax submissions.

Additional Information Requests (1-7 Days)

If Aetna needs more information, they'll contact the prescriber directly. Common requests include:

Missing Documentation:

  • Complete REMS enrollment confirmation
  • Detailed seizure frequency logs or EEG reports
  • Specific dosing and duration of failed prior medications
  • Updated echocardiogram if baseline is >3 months old

How to Respond Quickly:

  • Submit via the same method as original PA (fax or portal)
  • Include original PA reference number
  • Respond within 14 days to avoid denial for "no response"

Hold Queue Explained: Incomplete submissions enter a "pending additional information" status, suspending the review clock until documentation is received.

Decision Window & Outcomes

Aetna typically issues one of three decisions:

Approval: Coverage authorized for up to 12 months with specified quantity limits and REMS monitoring requirements. Approval letters include:

  • Effective dates and renewal timeline
  • Designated specialty pharmacy information
  • Required monitoring schedule (echocardiograms every 6 months)

Partial Approval: Coverage with modifications (different dosing, quantity limits, or additional monitoring requirements).

Denial: Most common reasons include insufficient documentation of ASM failures, missing REMS enrollment, or cardiac contraindications. Denial letters must include specific reasons and appeal rights under New Jersey law.

If Denied: New Jersey Appeals Process

New Jersey provides robust appeal rights through the Independent Health Care Appeals Program (IHCAP):

Internal Appeals (First Step)

Timeline: File within 180 days of denial Process: Submit appeal to Aetna with additional clinical evidence Decision: 30 days for standard appeals, 72 hours for expedited

External Review via IHCAP

After exhausting Aetna's internal appeals, New Jersey residents can access independent external review:

Filing Deadline: Within 60 days of final internal denial Process: Submit directly to Maximus Federal Services (New Jersey's contracted review organization) Timeline: 45 days for standard review, expedited for urgent cases Cost: Free to patients (insurers pay all review costs) Decision: Binding on Aetna if overturned

Contact Information:

  • IHCAP Hotline: 1-888-393-1062
  • NJ Department of Banking and Insurance: 1-800-446-7467

For patients and providers navigating complex insurance appeals, Counterforce Health helps turn denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to identify specific denial reasons and craft point-by-point rebuttals aligned with payer requirements.

Renewal Cycles & Reauthorization

Fintepla approvals typically require annual reauthorization with additional requirements:

When to Reauthorize: Submit 30-60 days before current approval expires Required Documentation:

  • Updated seizure frequency logs showing clinical benefit
  • All echocardiogram reports from the past 12 months
  • Confirmation of continued REMS compliance
  • Any changes in concomitant medications

What Speeds Renewals:

  • Documented seizure reduction (≥25% frequency decrease is often considered clinically meaningful)
  • No cardiac complications on serial echocardiograms
  • Maintained REMS compliance with no safety issues

Timeline Visual & Milestones

Milestone Standard Timeline Urgent Timeline Key Requirements
Pre-submission prep 1-2 days Same day REMS enrollment, baseline echo
Initial review 3-7 days 24-48 hours Complete PA form submission
Additional info requests 5-10 days 1-2 days Respond within 14 days
Final decision 15-30 days total 72 hours total All criteria met
Internal appeal 30 days 72 hours New clinical evidence
External review (IHCAP) 45 days Expedited Independent physician review

Time-Saving Tips

Portal Usage: Submit through Aetna's electronic prior authorization system when available for faster processing and real-time status updates.

Bundled Evidence: Include all required documentation in the initial submission to avoid back-and-forth requests.

Direct Specialty Routing: Work directly with CVS Specialty or designated Aetna specialty pharmacies who understand REMS requirements and can coordinate with the PA process.

Peer-to-Peer Strategy: If initial denial occurs, request a peer-to-peer review between the treating neurologist and Aetna's medical director before filing formal appeals.

Common Denial Reasons & Fixes

Denial Reason How to Overturn Required Documentation
Missing REMS enrollment Submit proof of prescriber, patient, and pharmacy REMS certification REMS confirmation letters or ID numbers
Insufficient prior therapy Document specific ASM trials with doses, durations, and failure reasons Detailed medication history with outcomes
Cardiac concerns Provide cardiology clearance if echo shows abnormalities Cardiology consultation notes
Non-formulary status Request medical exception with comparative effectiveness evidence Medical necessity letter citing FDA labeling
Age restriction Confirm patient ≥2 years with birth date documentation Medical records showing age eligibility

FAQ

How long does Aetna (CVS Health) PA take in New Jersey? Standard prior authorizations take 15-30 days, while urgent requests are decided within 72 hours when properly documented.

What if Fintepla (fenfluramine) is non-formulary on my plan? Request a medical exception through Aetna's formulary exception process, demonstrating that preferred alternatives are ineffective or contraindicated.

Can I request an expedited appeal in New Jersey? Yes, both Aetna internal appeals and IHCAP external reviews offer expedited timelines (72 hours and "as soon as possible" respectively) for urgent medical situations.

Does step therapy apply if I've failed medications outside New Jersey? Yes, documented medication failures from other states count toward step therapy requirements, provided you have complete medical records.

What happens if my echocardiogram shows abnormalities? Fintepla may still be approved with cardiology consultation confirming that benefits outweigh cardiac risks and establishing appropriate monitoring.

How much does Fintepla cost with Aetna coverage? Costs vary by plan, but Fintepla typically falls under specialty tier pricing. The manufacturer's copay program may reduce out-of-pocket costs to $0 for eligible patients.

Can my doctor file an external appeal on my behalf? Yes, New Jersey allows providers to file IHCAP external appeals with patient consent, streamlining the process for complex cases.

What if Aetna denies my appeal? After exhausting internal appeals, you have 60 days to file an external review with IHCAP. The independent review decision is binding on Aetna.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan details and medical circumstances. Always consult with your healthcare provider and insurance plan for specific guidance.

For additional assistance with New Jersey insurance appeals, contact the NJ Department of Banking and Insurance Consumer Hotline at 1-800-446-7467.

Healthcare coverage specialists like Counterforce Health can help patients and clinicians navigate complex prior authorization and appeal processes by analyzing denial letters and crafting evidence-based responses tailored to specific payer requirements.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.